.webp)
We are proud to welcome Deborah Zajac as a General Partner at SOSV/IndieBio, where she will play a pivotal role in backing deep tech startups focused on solving some of the world’s most urgent challenges in human and planetary health.
A Proven Leader in Corporate Venture Capital and Innovation
Deborah brings a wealth of experience in corporate venture capital, having led investment funds for Fortune 1000 companies at Touchdown Ventures. Prior to that, she held senior roles in investing and corporate development at GE Ventures and General Electric, where she also spun out ventures from GE and Columbia University.
Her career began in the startup ecosystem at Celarix.com, giving her a strong foundation in early-stage company building and innovation strategy.
Advancing the Mission of SOSV/IndieBio
At SOSV/IndieBio, Deborah joins a globally recognized team that backs science-driven startups in biotechnology, health tech, and climate tech. As part of the SOSV family, IndieBio is known for being “The First Check in Deep Tech”, providing not only pre-seed and seed-stage capital but also hands-on programming and lab resources to accelerate startup growth.
Deborah’s addition strengthens our mission to fund and scale startups working at the intersection of biology, sustainability, and human health.
Driving the Future of Human and Planetary Health
With her strategic leadership and deep domain expertise, Deborah will be instrumental in helping visionary founders turn cutting-edge science into transformative companies. Her track record aligns perfectly with IndieBio’s focus on high-impact innovation across sectors like synthetic biology, regenerative medicine, climate resilience, and next-gen therapeutics.
We look forward to the breakthroughs ahead as Deborah joins us in shaping the next wave of innovation for a healthier, more sustainable future.
